期刊文献+

系统性红斑狼疮合并肺动脉高压的研究进展 被引量:3

下载PDF
导出
摘要 系统性红斑狼疮(Systemic lupus erythematosus,SLE)是一种临床上常见的慢性炎症性自身免疫系统疾病,表现为多系统多脏器损害,几乎可以累及机体每一个器官。肺动脉高压(Pulmonary arterial hypertension,PAH)是一种累及到肺部小血管的疾病,即在静息状态下,经右心导管测得平均肺动脉压≥25mmHg的血流动力学状态,其根本原因是不断增加的肺循环阻力导致了肺动脉压力升高以及右心功能的衰竭。
机构地区 新疆医科大学
出处 《陕西医学杂志》 CAS 2014年第12期1687-1688,共2页 Shaanxi Medical Journal
  • 相关文献

参考文献11

  • 1Can MM,Kaymaz C,Tanboga IH,et al.Increased right ventricular glucose metabolism in patients with pulmonary arterialhypertension[J].Clin Nucl Med,2011,36:743-748.
  • 2周家蕃,张益民,李建国.系统性红斑狼疮合并肺动脉高压[J].新医学,2009,40(3):206-208. 被引量:5
  • 3Bonderman D,Wilkens H,Wakounig S,et al.Risk factors for chronic thromboembolic pulmonary hypertension[J].European Respiratory Journal,2009,33:325-331.
  • 4Quadrelli SA,Alvarez C,Arce SC,et al.Pulmonary involvement of systemic lupus erythematosus:analysis of90necropsies[J].Lupus 2009,18:1053-1060.
  • 5Rabinovitch M.Molecular pathogenesis of pulmonary arterial hypertension[J].Journal of Clinical Investigation2012,122:4306-4313.
  • 6Isgro J,Gupta S,Jacek E,et al.Enhanced Rho-associated protein kinase activation in patients with systemic lupus erythematosus[J].Arthritis&Rheumatism2013,65:1592-602.
  • 7Shahane A.Pulmonary hypertension in rheumatic diseases:epidemiology and pathogenesis[J].Rheumatology International,2013,33:1655-1667.
  • 8Chung L,Liu J,Parsons L,Hassoun PM,et al.Characterization of connective tissue diseaseassociated pulmonary arterial hypertension from REVEAL:identifying systemic sclerosis as a unique phenotype[J].Chest,2010,138:1383-1394.
  • 9Cefle A,Inanc M,Sayarlioglu M,et al.Pulmonary hypertension in systemic lupus erythematosus:relationship with antiphospholipid antibodies and severe disease outcome[J].Rheumatology International,2011,31:183-189.
  • 10Montani D,Savale L,Natali D,et al.Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension[J].European Heart Journal,2010,31:1898–1907.

二级参考文献11

  • 1周敏,徐永健.肺动脉高压的治疗进展──呼吸系统疾病(6)[J].新医学,2006,37(1):57-59. 被引量:4
  • 2DORFMU LLER P, HUMBERT M, PERROS F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases[J]. Hum Pathol, 2007, 38 (6): 893 -902.
  • 3CHEEVER K H. An overview of pulmonary arterial hypertension : risks, pathogenesis, clinical manifestations, and management[ J]. J Cardiovasc Nurs, 2005, 20 (2): 108-116.
  • 4PEREZ-VILLA F, FONT J, AZQUETA M, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study[ J]. Arthritis Rheum, 2005, 53 (3) : 460-467.
  • 5RODRIGUEZ-VITA J, RUIZ-ORTEGA M, RUPEREZ M, et al. Endothelin-1, via ETA receptor and inde- pendently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells[J]. Circ Res, 2005, 97 (2): 125-134.
  • 6HOUMAN M H, SMITI-KHANFIR M, BEN GHORBELL I, et al. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients [J]. Lupus, 2004, 13 (3): 204-211.
  • 7GONZALEZ-LOPEZ L, CARDONA-MUNOZ E G, CELIS A, et al. Therapy with intermittent pulse cyelo- phosphamide for pulmonary hypertension associated with systemic lupus erythematosus [ J ]. Lupus, 2004, 13 (2) : 105-112.
  • 8SABLOTZKI A, HENTSCHEL T, HOFMANN S, et al. Inhaled aerosolized iloprost in the evaluation of heart transplant candidates experiences with 45 cases [ J ]. J Clin Anesth, 2006, 18 (2) : 108-113.
  • 9AHMADI-SIMAB K, LAMPRECHT P, GROSS W L. Successful therapy of bosentan-refractory pulmonary arterial hypertension (PAH) with inhalative iloprost [ J ]. Clin Exp Rheumatol, 2005, 23 (3): 402-403.
  • 10HAAS C. Pulmonary hypertension associated with systemic lupus erythematosus [ J]. Bull Acad Natl Med (法文), 2004, 188 (6): 985-987.

共引文献4

同被引文献20

引证文献3

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部